bf/NASDAQ:VBIV_icon.jpeg

COM:VBIVACCINES

VBI Vaccines Inc.

  • Stock

Last Close

0.13

07/08 20:00

Market Cap

21.57M

Beta: -

Volume Today

27.93M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.00
-
658.00K
-
1.07M
63.07%
809K
24.60%
849.50K
5.01%
993K
16.89%
1.61M
62.49%
2.36M
46.51%
4.59M
94.06%
7.55M
64.56%
average payables
167.41K
-
194.64K
16.27%
291.47K
49.74%
1.21M
316.17%
1.91M
57.79%
3.93M
105.46%
3.59M
8.68%
2.43M
32.32%
4.01M
64.86%
8.63M
115.29%
9.70M
12.47%
average receivables
42.63K
-
44.06K
3.33%
98.68K
124.00%
84K
14.88%
76.50K
8.93%
99.50K
30.07%
128.50K
29.15%
139K
8.17%
42.50K
69.42%
51K
20%
47K
7.84%
book value per share
942.23
-
374.79
60.22%
59.36
84.16%
83.61
40.85%
81.38
2.67%
44.85
44.89%
22.17
50.57%
23.60
6.47%
16.93
28.26%
0.25
98.53%
0.00
99.81%
capex per share
-11.77
-
-9.08
22.89%
-1.30
85.63%
-0.58
55.20%
-0.43
25.57%
-2.74
529.88%
-0.92
66.32%
-0.14
85.10%
-0.23
70.80%
-0.02
92.83%
-0.00
99.67%
capex to depreciation
-64.36
-
-64.36
0%
-0.48
99.25%
-0.97
100.45%
-0.88
9.18%
-11.06
1,161.21%
-3.05
72.41%
-0.61
80.16%
-1.09
79.60%
-2.11
93.87%
-0.44
79.33%
capex to operating cash flow
0.40
-
0.40
0%
0.06
84.75%
0.03
47.94%
0.02
35.45%
0.13
545.36%
0.08
42.71%
0.02
71.81%
0.05
135.20%
0.06
17.91%
0.01
75.84%
capex to revenue
-0.57
-
-1.07
85.70%
-0.74
30.69%
-1.79
141.43%
-1.65
7.42%
-0.94
43.01%
-3.16
235.45%
-4.01
26.98%
-0.10
97.51%
cash per share
226.44
-
182.56
19.38%
29.88
83.63%
32.24
7.88%
45.99
42.67%
27.09
41.10%
11.10
59.00%
16.37
47.42%
14.32
12.52%
0.24
98.31%
0.00
99.37%
days of inventory on hand
127.92
-
82.53
35.49%
55.39
32.89%
73.74
33.15%
49.64
32.68%
85.68
72.59%
87.30
1.90%
213.61
144.68%
248.03
16.12%
days payables outstanding
39.66
-
200.65
405.93%
127.22
36.60%
490.15
285.28%
52.04
89.38%
148.66
185.64%
145.05
2.43%
419.93
189.51%
187.68
55.31%
days sales outstanding
60.39
-
6.66
88.97%
60.34
805.94%
6.09
89.90%
33.03
442.19%
26.49
19.81%
4.63
82.53%
31.71
585.24%
debt to assets
0.11
-
0.09
20.97%
0.10
13.01%
0.13
25.73%
0.09
33.32%
0.15
76.95%
0.34
122.70%
0.61
81.14%
debt to equity
0.14
-
0.11
23.19%
0.14
30.33%
0.18
24.15%
0.10
41.28%
0.22
112.08%
0.81
268.32%
7.05
765.74%
dividend yield
earnings yield
-0.09
-
-0.05
47.90%
-0.22
368.92%
-0.25
10.90%
-0.21
17.00%
-0.61
192.79%
-0.34
44.09%
-0.08
76.73%
-0.12
54.58%
-0.05
61.69%
-0.01
78.25%
enterprise value
12.25M
-
69.13M
464.28%
53.20M
23.05%
72.81M
36.86%
134.00M
84.05%
59.79M
55.38%
135.47M
126.56%
507.36M
274.52%
506.68M
0.13%
3.01B
494.30%
9.18B
204.80%
enterprise value over ebitda
-2.27
-
-12.79
464.28%
-5.43
57.56%
-3.00
44.68%
-3.67
22.08%
-1.01
72.47%
-2.94
191.11%
-11.63
295.90%
-7.45
35.97%
-36.80
394.15%
-114.86
212.08%
ev to operating cash flow
-2.49
-
-14.03
464.28%
-5.88
58.10%
-3.93
33.13%
-4.27
8.60%
-1.31
69.25%
-2.78
111.77%
-10.78
287.75%
-12.70
17.74%
-40.86
221.83%
-150.75
268.94%
ev to sales
55.71
-
132.86
138.50%
154.92
16.60%
17.82
88.50%
60.99
242.24%
478.19
683.99%
802.98
67.92%
2.78K
246.59%
1.06K
62.01%
free cash flow per share
-41.35
-
-31.89
22.89%
-22.79
28.52%
-19.07
16.32%
-21.75
14.05%
-23.55
8.24%
-13.16
44.12%
-6.60
49.80%
-4.93
25.34%
-0.30
93.87%
-0.00
98.69%
free cash flow yield
-0.14
-
-0.07
47.90%
-0.15
103.45%
-0.21
40.37%
-0.17
17.20%
-0.49
188.87%
-0.32
35.22%
-0.08
74.81%
-0.07
12.26%
-0.03
63.23%
-0.01
73.87%
graham net net
225.12
-
181.43
19.41%
20.90
88.48%
11.66
44.18%
28.76
146.52%
9.27
67.75%
2.75
70.33%
11.35
312.45%
6.66
41.32%
-0.10
101.45%
-0.00
96.57%
graham number
764.74
-
423.53
44.62%
216.36
48.92%
208.78
3.50%
220.24
5.49%
171.25
22.25%
83.61
51.18%
58.75
29.74%
57.07
2.86%
1.75
96.94%
0.01
99.54%
income quality
1.07
-
1.07
0%
0.61
42.82%
0.80
30.14%
0.80
0.85%
0.72
11.04%
0.89
24.13%
1.02
14.52%
0.57
43.78%
0.65
13.68%
0.66
0.83%
intangibles to total assets
0
-
0
0.45
Infinity%
0.65
45.28%
0.50
23.40%
0.48
2.63%
0.52
6.60%
0.31
40.29%
0.31
0.53%
0.39
27.41%
0.43
10.99%
interest coverage
-7.83
-
-76.70
879.12%
-12.94
83.13%
-18.56
43.51%
-23.86
28.53%
-16.11
32.50%
-14.38
10.74%
-20.42
42.03%
12.48
161.14%
interest debt per share
2.68
-
12.26
357.67%
10.88
11.24%
7.90
27.44%
4.49
43.20%
2.83
36.87%
4.30
51.81%
0.22
94.93%
0.00
98.62%
inventory turnover
2.85
-
4.42
55.01%
6.59
49.00%
4.95
24.89%
7.35
48.55%
4.26
42.06%
4.18
1.86%
1.71
59.13%
1.47
13.88%
invested capital
0.14
-
0.11
23.19%
0.14
30.33%
0.18
24.15%
0.10
41.28%
0.22
112.08%
0.81
268.32%
7.05
765.74%
market cap
49.96M
-
95.89M
91.93%
65.68M
31.51%
93.13M
41.81%
188.56M
102.46%
105.04M
44.29%
164.84M
56.93%
600.24M
264.14%
596.58M
0.61%
3.02B
406.49%
9.15B
202.78%
net current asset value
37.55M
-
39.25M
4.52%
9.96M
74.62%
13.34M
33.85%
44.56M
234.14%
22.26M
50.04%
13.02M
41.52%
94.37M
625.01%
63.89M
32.30%
-13.23M
120.71%
-43.19M
226.40%
net debt to ebitda
6.98
-
4.95
29.04%
1.27
74.29%
0.84
34.14%
1.49
78.04%
0.76
48.84%
0.64
16.59%
2.13
234.32%
1.32
37.95%
0.13
90.38%
-0.37
388.89%
net income per share
-27.59
-
-21.27
22.89%
-35.05
64.76%
-23.17
33.88%
-26.49
14.33%
-29.06
9.71%
-14.02
51.78%
-6.50
53.63%
-8.55
31.54%
-0.55
93.62%
-0.01
98.91%
operating cash flow per share
-29.58
-
-22.81
22.89%
-21.49
5.79%
-18.49
13.96%
-21.32
15.30%
-20.81
2.40%
-12.23
41.20%
-6.47
47.14%
-4.70
27.38%
-0.29
93.92%
-0.00
98.63%
payables turnover
9.20
-
1.82
80.23%
2.87
57.72%
0.74
74.04%
7.01
841.80%
2.46
64.99%
2.52
2.49%
0.87
65.46%
1.94
123.75%
receivables turnover
6.04
-
54.80
806.64%
6.05
88.96%
59.91
890.43%
11.05
81.56%
13.78
24.70%
78.88
472.42%
11.51
85.41%
research and ddevelopement to revenue
0.65
-
18.19
2,710.32%
24.18
32.97%
11.47
52.59%
11.86
3.40%
14.00
18.12%
31.00
121.32%
14.33
53.76%
1.08
92.49%
return on tangible assets
-0.03
-
-0.06
93.51%
-0.90
1,493.68%
-0.63
30.17%
-0.53
15.54%
-0.89
68.27%
-0.94
5.30%
-0.33
65.37%
-0.50
52.62%
-1.49
199.23%
-1.88
26.35%
revenue per share
2.27
-
0.55
75.88%
0.59
7.39%
1.53
160.90%
0.56
63.62%
0.15
73.86%
0.07
49.08%
0.00
94.36%
0.00
86.69%
roe
-0.03
-
-0.06
93.87%
-0.59
940.19%
-0.28
53.06%
-0.33
17.46%
-0.65
99.09%
-0.63
2.44%
-0.28
56.45%
-0.50
83.35%
-2.20
335.07%
-12.33
461.45%
roic
-0.03
-
-0.05
93.87%
-0.35
574.51%
-0.24
31.18%
-0.28
15.01%
-0.54
95.87%
-0.51
6.82%
-0.23
53.75%
-0.40
69.04%
-0.85
114.81%
-1.32
55.19%
sales general and administrative to revenue
7.00
-
21.46
206.69%
13.91
35.18%
6.20
55.46%
6.34
2.41%
19.46
206.76%
60.75
212.13%
51.87
14.63%
shareholders equity per share
942.23
-
374.79
60.22%
59.36
84.16%
83.61
40.85%
81.38
2.67%
44.85
44.89%
22.17
50.57%
23.60
6.47%
16.93
28.26%
0.25
98.53%
0.00
99.81%
stock based compensation to revenue
2.23
-
4.60
106.55%
2.79
39.44%
0.99
64.57%
1.77
79.47%
4.98
181.25%
15.26
206.21%
8.96
41.26%
0.77
91.44%
tangible asset value
156.92M
-
80.95M
48.42%
11.81M
85.41%
15.84M
34.13%
47.48M
199.75%
31.62M
33.40%
25.29M
20.01%
107.29M
324.21%
79.53M
25.87%
3.69M
95.36%
-30.10M
915.55%
tangible book value per share
942.23
-
374.79
60.22%
28.05
92.52%
15.82
43.61%
32.25
103.93%
14.45
55.20%
6.35
56.04%
14.75
132.15%
9.36
36.54%
0.01
99.85%
-0.00
113.53%
working capital
37.55M
-
39.25M
4.52%
11.59M
70.46%
26.74M
130.69%
57.19M
113.84%
38.35M
32.94%
17.21M
55.14%
114.69M
566.59%
97.70M
14.82%
40.75M
58.29%
-39.51M
196.95%

All numbers in (except ratios and percentages)